Literature DB >> 25520164

Add-on lithium for the treatment of unipolar depression: too often forgotten?

Fabrice Jollant1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25520164      PMCID： PMC4275336          DOI： 10.1503/jpn.140162

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  12 in total

Review 1.  Lithium toxicity profile: a systematic review and meta-analysis.

Authors:  Rebecca F McKnight; Marc Adida; Katie Budge; Sarah Stockton; Guy M Goodwin; John R Geddes
Journal:  Lancet       Date:  2012-01-20       Impact factor: 79.321

Review 2.  Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

Authors:  S J Edwards; V Hamilton; L Nherera; N Trevor
Journal:  Health Technol Assess       Date:  2013-11       Impact factor: 4.014

3.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

4.  Predictors of efficacy in lithium augmentation for treatment-resistant depression.

Authors:  Hiroko Sugawara; Kaoru Sakamoto; Tsuyoto Harada; Jun Ishigooka
Journal:  J Affect Disord       Date:  2010-01-20       Impact factor: 4.839

Review 5.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Toshiaki A Furukawa; Georgia Salanti; John R Geddes; Julian Pt Higgins; Rachel Churchill; Norio Watanabe; Atsuo Nakagawa; Ichiro M Omori; Hugh McGuire; Michele Tansella; Corrado Barbui
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

6.  Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.

Authors:  Nicolas Andres Crossley; Michael Bauer
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

7.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

Review 8.  Role of lithium augmentation in the management of major depressive disorder.

Authors:  Michael Bauer; Mazda Adli; Roland Ricken; Emanuel Severus; Maximilian Pilhatsch
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

9.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

Authors:  Raymond W Lam; Sidney H Kennedy; Sophie Grigoriadis; Roger S McIntyre; Roumen Milev; Rajamannar Ramasubbu; Sagar V Parikh; Scott B Patten; Arun V Ravindran
Journal:  J Affect Disord       Date:  2009-08-11       Impact factor: 4.839

Review 10.  Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis.

Authors:  Andrea Cipriani; Keith Hawton; Sarah Stockton; John R Geddes
Journal:  BMJ       Date:  2013-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.